BioCentury | Mar 10, 2016
Distillery Therapeutics

Therapeutics: Thymic stromal lymphopoietin (TSLP)

...include testing promotion of dermal TSLP expression in xenograft models of breast and pancreatic cancers. Lipidor AB...
BioCentury | Sep 2, 2013
Clinical News

Akvano/calcipotriol: Phase I/IIa data

...the primary endpoint of reducing psoriatic infiltrate thickness as measured by sonography vs. placebo (p<0.0001). Lipidor...
...in Lipidor, which said it is preparing to out-license the product or sell the company. Lipidor AB...
Items per page:
1 - 2 of 2
BioCentury | Mar 10, 2016
Distillery Therapeutics

Therapeutics: Thymic stromal lymphopoietin (TSLP)

...include testing promotion of dermal TSLP expression in xenograft models of breast and pancreatic cancers. Lipidor AB...
BioCentury | Sep 2, 2013
Clinical News

Akvano/calcipotriol: Phase I/IIa data

...the primary endpoint of reducing psoriatic infiltrate thickness as measured by sonography vs. placebo (p<0.0001). Lipidor...
...in Lipidor, which said it is preparing to out-license the product or sell the company. Lipidor AB...
Items per page:
1 - 2 of 2